# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-067732
Filing Date
2024-08-12
Accepted
2024-08-12 16:51:13
Documents
58
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0210893-10q_citius.htm iXBRL | 10-Q | 588544
2 | AT THE MARKET OFFERING AGREEMENT | ea021089301ex1-1_citius.htm | EX-1.1 | 214665
3 | LEGEL OPINION | ea021089301ex5-1_citius.htm | EX-5.1 | 5779
4 | CERTIFICATION | ea021089301ex31-1_citius.htm | EX-31.1 | 9740
5 | CERTIFICATION | ea021089301ex31-2_citius.htm | EX-31.2 | 10903
6 | CERTIFICATION | ea021089301ex32-1_citius.htm | EX-32.1 | 4642
| Complete submission text file | 0001213900-24-067732.txt |  | 4285944

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL SCHEMA FILE | ctxr-20240630.xsd | EX-101.SCH | 40793
8 | XBRL CALCULATION FILE | ctxr-20240630_cal.xml | EX-101.CAL | 31516
9 | XBRL DEFINITION FILE | ctxr-20240630_def.xml | EX-101.DEF | 192225
10 | XBRL LABEL FILE | ctxr-20240630_lab.xml | EX-101.LAB | 350259
11 | XBRL PRESENTATION FILE | ctxr-20240630_pre.xml | EX-101.PRE | 185814
61 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0210893-10q_citius_htm.xml | XML | 377687

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Filer) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-38174 | Film No.: 241197644
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)